UB
Unravel Biosciences, Inc.
SEC filingBiotechnology · Medford, MA
Amount raised$4.1Msold at filing
Total offering$4.5M$400K still open
Investors in the raise2count reported to the SEC
FiledAug 24, 2026first sale Aug 7, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Donald IngberDirector
Richard NovakExecutive Officer, Director
Frederic VigneaultDirector
Executive officers, directors and promoters as listed on the Form D.